Author Question: There is more than one circadian clock. Early evidence for this was that bilateral lesions of the ... (Read 61 times)

karlynnae

  • Hero Member
  • *****
  • Posts: 599
There is more than one circadian clock. Early evidence for this was that bilateral lesions of the
 
  A) suprachiasmatic nuclei abolish all circadian rhythms.
  B) suprachiasmatic nuclei do not abolish circadian rhythms.
  C) raph nucleus abolish sleep.
  D) raph nucleus abolish wakefulness.
  E) suprachiasmatic nuclei abolish sleep.

Question 2

The first circadian gene to be discovered in mammals was
 
  A) clock.
  B) alarm.
  C) circa.
  D) tau.
  E) invert.



jjorrostieta

  • Sr. Member
  • ****
  • Posts: 298
Answer to Question 1

Answer: B

Answer to Question 2

Answer: D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library